KALA BIO, Inc. (LON:0JQ2)
0.3850
-0.0052 (-1.33%)
Feb 12, 2026, 3:16 PM GMT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of 7.53 million as of February 12, 2026. Its market cap has decreased by -82.46% in one year.
Market Cap
7.53M
Enterprise Value
14.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from 331.29M to 7.53M, a decrease of -97.73%. That is a compound annual growth rate of -35.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 8.28M | -13.80% |
| Dec 31, 2025 | 9.60M | -63.54% |
| Dec 31, 2024 | 26.33M | 77.93% |
| Dec 29, 2023 | 14.80M | -70.70% |
| Dec 30, 2022 | 50.51M | -13.71% |
| Dec 31, 2021 | 58.53M | -78.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| IXICO | 9.50M |
| Genflow Biosciences | 9.38M |
| RUA Life Sciences | 8.84M |
| GENinCode | 8.10M |